S&P 500

5.655,95

0,44%

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ARDX

Ardelyx (ARDX)

Ardelyx Inc

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:ARDX

<< Previous 19 20 21 22 23 24 25 26 27 28 29 30 31 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
09/06/2015	22h46	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARDX	Ardelyx Inc
09/06/2015	22h45	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARDX	Ardelyx Inc
09/06/2015	22h43	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARDX	Ardelyx Inc
09/06/2015	22h43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
09/06/2015	22h43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
09/06/2015	22h42	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
08/06/2015	23h09	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
05/06/2015	23h14	Edgar (US Regulatory)	Statement of Ownership (sc 13g)	NASDAQ:ARDX	Ardelyx Inc
03/06/2015	13h41	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
03/06/2015	13h38	Dow Jones News	Ardelyx Ends Development Agreement With AstraZeneca	NASDAQ:ARDX	Ardelyx Inc
03/06/2015	12h19	PR Newswire (US)	Ardelyx Regains Worldwide Development and Commercialization Rights for Its Late-Stage Development Candidate, Tenapanor, and R...	NASDAQ:ARDX	Ardelyx Inc
03/06/2015	12h19	PR Newswire (US)	Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia t...	NASDAQ:ARDX	Ardelyx Inc
19/05/2015	20h52	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
19/05/2015	20h50	PR Newswire (US)	Ardelyx Presents Positive Results from Its Phase 2b Clinical Trial Evaluating Tenapanor in IBS-C Patients at Digestive Diseas...	NASDAQ:ARDX	Ardelyx Inc
12/05/2015	22h15	PR Newswire (US)	Ardelyx Reports First Quarter 2015 Financial Results	NASDAQ:ARDX	Ardelyx Inc
12/05/2015	22h12	Edgar (US Regulatory)	Quarterly Report (10-q)	NASDAQ:ARDX	Ardelyx Inc
06/05/2015	16h10	Analyst Ratings Network	Ardelyx PT Lowered to $22.00 at Leerink Swann (ARDX)	NASDAQ:ARDX	Ardelyx Inc
06/05/2015	16h10	Analyst Ratings Network	Ardelyx PT Lowered to $24.00 (ARDX)	NASDAQ:ARDX	Ardelyx Inc
06/05/2015	00h42	Dow Jones News	Ardelyx's Mid-Stage Clinical Trial Fails to Meet Primary EndPoint	NASDAQ:ARDX	Ardelyx Inc
05/05/2015	22h05	PR Newswire (US)	Ardelyx Reports Results from Phase 2a Clinical Trial Evaluating Tenapanor in Chronic Kidney Disease Patients with Type 2 Diab...	NASDAQ:ARDX	Ardelyx Inc
24/04/2015	22h49	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ARDX	Ardelyx Inc
24/04/2015	22h48	Edgar (US Regulatory)	Proxy Statement (definitive) (def 14a)	NASDAQ:ARDX	Ardelyx Inc
21/04/2015	23h56	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
21/04/2015	23h54	Edgar (US Regulatory)	Initial Statement of Beneficial Ownership (3)	NASDAQ:ARDX	Ardelyx Inc
20/04/2015	23h03	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ARDX	Ardelyx Inc
20/04/2015	15h00	PR Newswire (US)	Ardelyx Appoints Dr. Annalisa Jenkins to Its Board of Directors	NASDAQ:ARDX	Ardelyx Inc
10/04/2015	22h24	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
08/04/2015	23h32	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ARDX	Ardelyx Inc
13/03/2015	14h00	PR Newswire (US)	Ardelyx to Present at the 22nd Annual Future Leaders in the Biotech Industry Conference	NASDAQ:ARDX	Ardelyx Inc
13/03/2015	00h34	Edgar (US Regulatory)	Amended Statement of Changes in Beneficial Ownership (4/a)	NASDAQ:ARDX	Ardelyx Inc